Jonathan S. Berg - Concepedia

Author

Jonathan S. Berg

University of North Carolina at Chapel Hill ORCID

Also Known As

Amendola, Laura M., Anton-Culver, Hoda, Belmont, John W., Bensen, J.T., Berg, Jonathan, Berg, Jonathan S, Berg, Jonathan S., Bizon, Chris, Boggess, Kim A., Bombard, Yvonne

330

Publications

21.3K

Citations

H-Index

187

Concepts

All Affiliations

University of North Carolina at Chapel Hill Baylor College of Medicine National Human Genome Research Institute Harvard University Broad Institute

About

Jonathan S. Berg is an author at University of North Carolina at Chapel Hill specializing in medicine, genetics, and genomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	69	14.2K
2	Engineering	6	6	854
3	Education	4	4	267
4	Health Sciences	4	4	660
5	Management	2	2	247

Jonathan S. Berg

112

Publications

17.6K

Citations

H-Index

Page 1

	Year	Citations
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing Robert C. Green, Jonathan S. Berg, Wayne W. Grody, Genetics in Medicine Next-generation SequencingAcmg RecommendationsDiagnosisPathologyPersonal Genomics	2013	2.5K
ClinGen — The Clinical Genome Resource Heidi L. Rehm, Jonathan S. Berg, Lisa Brooks, New England Journal of Medicine Clinical Genome ResourceGenetic TestingFamily MembersCardiometabolic RiskGenetics	2015	1.5K
Dnmt3a is essential for hematopoietic stem cell differentiation Grant A. Challen, Deqiang Sun, Mira Jeong, Nature Genetics MedicineStem Cell MobilizationStem Cell ResearchStem CellsCell Biology	2011	1.1K
ACMG clinical laboratory standards for next-generation sequencing Heidi L. Rehm, Sherri J. Bale, Pınar Bayrak‐Toydemir, Genetics in Medicine Translational MedicineDna SequencingSequencingMedicineNext-generation Sequencing	2013	910
Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities Nicola Brunetti‐Pierri, Jonathan S. Berg, Fernando Scaglia, Nature Genetics Developmental AnomalyDevelopmental BiologyBrain DevelopmentRecurrent Reciprocal 1Q21.1Genetics	2008	627
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework Sarah E. Brnich, Ahmad Abou Tayoun, Fergus J. Couch, Genome Medicine	2019	571
Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium Laura M. Amendola, Gail P. Jarvik, Michael C. Leo, The American Journal of Human Genetics SequencingMedicineGeneticsNext-generation SequencingGenetic Epidemiology	2016	564
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource Natasha T. Strande, Erin Rooney Riggs, Adam H. Buchanan, The American Journal of Human Genetics Clinical Genome ResourceGene-disease AssociationsGenome-wide Association StudyClinical ValidityMedicine	2017	536
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria Vikas Pejaver, Alicia B. Byrne, Bing Feng, The American Journal of Human Genetics	2022	471
Myosin-X is an unconventional myosin that undergoes intrafilopodial motility Jonathan S. Berg, Richard E. Cheney Nature Cell Biology Molecular PhysiologyNatural SciencesUnconventional MyosinMolecular BiologyCytoskeleton	2002	372

Page 1